Programación epigenética placentaria en restricción del crecimiento intrauterino

Revista Chilena de Pediatría - Tập 87 - Trang 154-161 - 2016
Paola Casanello1,2, José A. Castro-Rodríguez2, Ricardo Uauy2, Bernardo J. Krause2
1División de Obstetricia y Ginecología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
2División de Pediatría, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Tài liệu tham khảo

Hales, 2001, The thrifty phenotype hypothesis, Br Med Bull, 60, 5, 10.1093/bmb/60.1.5 Vuguin, 2007, Animal models for small for gestational age and fetal programming of adult disease, Horm Res, 68, 113, 10.1159/000100545 Fowden, 2006, Intrauterine programming of physiological systems: Causes and consequences, Physiology (Bethesda), 21, 29, 10.1152/physiol.00050.2005 Gluckman, 2009, Epigenetic mechanisms that underpin metabolic and cardiovascular diseases, Nat Rev Endocrinol, 5, 401, 10.1038/nrendo.2009.102 Solomons, 2009, Developmental origins of health and disease: Concepts, caveats, and consequences for public health nutrition, Nutr Rev, 67, S12, 10.1111/j.1753-4887.2009.00152.x Devaskar, 2007, Metabolic programming in the pathogenesis of insulin resistance, Rev Endocr Metab Disord, 8, 105, 10.1007/s11154-007-9050-4 Krause, 2013, Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses, Epigenetics, 8, 944, 10.4161/epi.25579 Ohtani, 2011, Epigenetic regulation of cardiovascular differentiation, Cardiovasc Res, 90, 404, 10.1093/cvr/cvr019 Alarcón, 2008, Curvas antropométricas de recién nacidos chilenos, Rev Chil Pediatr, 79, 364, 10.4067/S0370-41062008000400003 Zhang, 2010, Defining normal and abnormal fetal growth: Promises and challenges, Am J Obstet Gynecol, 202, 522, 10.1016/j.ajog.2009.10.889 Carvajal, 2007, [Under diagnosis of fetal growth restriction by the new growth curves of the Chilean Ministry of Health], Rev Med Chil, 135, 436 Pallotto, 2006, Perinatal outcome and later implications of intrauterine growth restriction, Clin Obstet Gynecol, 49, 257, 10.1097/00003081-200606000-00008 Hendrix, 2008, Non-placental causes of intrauterine growth restriction, Semin Perinatol, 32, 161, 10.1053/j.semperi.2008.02.004 Crispi, 2010, Fetal growth restriction results in remodeled and less efficient hearts in children, Circulation, 121, 2427, 10.1161/CIRCULATIONAHA.110.937995 Jansson, 2007, Role of the placenta in fetal programming: Underlying mechanisms and potential interventional approaches, Clin Sci (Lond), 113, 1, 10.1042/CS20060339 Gagnon, 2006, An obstetric point of view on fetal adaptation and reprogramming, NeoReviews, 7, e189, 10.1542/neo.7-4-e189 Fowden, 2008, The placenta and intrauterine programming, J Neuroendocrinol, 20, 439, 10.1111/j.1365-2826.2008.01663.x Gatford, 2010, Review: Placental programming of postnatal diabetes and impaired insulin action after IUGR, Placenta, 31, S60, 10.1016/j.placenta.2009.12.015 Sutton, 1990, Changes in placental blood flow in the normal human fetus with gestational age, Pediatr Res, 28, 383, 10.1203/00006450-199010000-00016 Poston, 1997, The control of blood flow to the placenta, Exp Physiol, 82, 377, 10.1113/expphysiol.1997.sp004033 Adamson, 1999, Arterial pressure, vascular input impedance, and resistance as determinants of pulsatile blood flow in the umbilical artery, Eur J Obstet Gynecol Reprod Biol, 84, 119, 10.1016/S0301-2115(98)00320-0 Raio, 2003, Umbilical cord morphologic characteristics and umbilical artery Doppler parameters in intrauterine growth-restricted fetuses, J Ultrasound Med, 22, 1341, 10.7863/jum.2003.22.12.1341 Krause, 2011, Role of nitric oxide in placental vascular development and function, Placenta, 32, 797, 10.1016/j.placenta.2011.06.025 Myatt, 1992, Control of vascular resistance in the human placenta, Placenta, 13, 329, 10.1016/0143-4004(92)90057-Z Sweeney, 2006, Ultrastructural features of smooth muscle and endothelial cells of isolated isobaric human placental and maternal arteries, Placenta, 27, 635, 10.1016/j.placenta.2005.05.010 Learmont, 1996, Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries, Am J Obstet Gynecol, 174, 583, 10.1016/S0002-9378(96)70432-5 Boo, 2003, Flow-dependent regulation of endothelial nitric oxide synthase: Role of protein kinases, Am J Physiol Cell Physiol, 285, C499, 10.1152/ajpcell.00122.2003 Li, 2004, Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells, Biol Reprod, 70, 785, 10.1095/biolreprod.103.022293 Pardi, 2002, Placental-fetal interrelationship in IUGR fetuses--a review, Placenta, 23, S136, 10.1053/plac.2002.0802 Casanello, 2002, Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells, Circ Res, 91, 127, 10.1161/01.RES.0000027813.55750.E7 Casanello, 2009, Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia, Placenta, 30, 625, 10.1016/j.placenta.2009.04.010 Krause, 2013, Endothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels, Placenta, 34, 20, 10.1016/j.placenta.2012.09.015 Moncada, 2006, The discovery of nitric oxide and its role in vascular biology, Br J Pharmacol, 147, S193, 10.1038/sj.bjp.0706458 Thomas, 2008, The chemical biology of nitric oxide: implications in cellular signaling, Free Radic Biol Med, 45, 18, 10.1016/j.freeradbiomed.2008.03.020 Balligand, 2009, eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues, Physiol Rev, 89, 481, 10.1152/physrev.00042.2007 Fleming, 2001, Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity, Circ Res, 88, E68, 10.1161/hh1101.092677 Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224 Closs, 2000, Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: Role of cationic amino acid transporters, Mol Pharmacol, 57, 68 Boo, 2006, Coordinated regulation of endothelial nitric oxide synthase activity by phosphorylation and subcellular localization, Free Radic Biol Med, 41, 144, 10.1016/j.freeradbiomed.2006.03.024 Boo, 2003, synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase, Free Radical Biology and Medicine, 35, 729, 10.1016/S0891-5849(03)00397-6 Butt, 2000, Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases, J Biol Chem, 275, 5179, 10.1074/jbc.275.7.5179 Santhanam, 2008, Arginase and vascular aging, J Appl Physiol, 105, 1632, 10.1152/japplphysiol.90627.2008 Prieto, 2011, Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium, Placenta, 32, 932, 10.1016/j.placenta.2011.09.003 Krause, 2012, Role of arginase-2 and eNOS in the differential vascular reactivity and hypoxia-induced endothelial response in umbilical arteries and veins, Placenta, 33, 360, 10.1016/j.placenta.2012.02.006 Prieto, 2010, Hypoxia-reduced eNOS activity could be explained by higher arginase II activity and cellular redistribution in human umbilical vein endothelial cells, Reprod Sci, 17 Casanello, 2007, Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: Implications in foetal endothelial dysfunction in human pregnancy diseases, Curr Vasc Pharmacol, 5, 69, 10.2174/157016107779317198 Herrera, 2014, The placental pursuit for an adequate oxidant balance between the mother and the fetus, Front Pharmacol, 5, 149, 10.3389/fphar.2014.00149 Burton, 2009, Oxygen the Janus gas; its effects on human placental development and function, J Anat, 215, 27, 10.1111/j.1469-7580.2008.00978.x Loboda, 2010, HIF-1 and HIF-2 transcription factors--similar but not identical, Mol Cells, 29, 435, 10.1007/s10059-010-0067-2 Klose, 2006, Genomic DNA methylation: The mark and its mediators, Trends Biochem Sci, 31, 89, 10.1016/j.tibs.2005.12.008 Takeda, 2010, Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis, Genes Dev, 24, 491, 10.1101/gad.1881410 Stempien-Otero, 1999, Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis, J Biol Chem, 274, 8039, 10.1074/jbc.274.12.8039 Matsushita, 2000, Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: In vivo evidence of the importance of NF-kappaB in endothelial cell regulation, Circ Res, 86, 974, 10.1161/01.RES.86.9.974 Ock, 2011, A novel approach for stress-induced gastritis based on paradoxical anti-oxidative and anti-inflammatory action of exogenous 8-hydroxydeoxyguanosine, Biochem Pharmacol, 81, 111, 10.1016/j.bcp.2010.08.023 Giannubilo, 2008, Doppler analysis and placental nitric oxide synthase expression during fetal growth restriction, J Matern Fetal Neona, 21, 617, 10.1080/14767050802214774 Sobrevia, 2011, Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes, Placenta, 32, S159, 10.1016/j.placenta.2010.12.011 Myatt, 2010, Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta, Placenta, 31, S66, 10.1016/j.placenta.2009.12.021 Noris, 2004, L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species, Hypertension, 43, 614, 10.1161/01.HYP.0000116220.39793.c9 Munoz, 2010, Participation of arginases in the vascular tone in umbilical vein from iugr placentae: Role of the endothelium and hypoxia, Placenta, 31 Krause, 2009, Epigenetics: New concepts of old phenomena in vascular physiology, Curr Vasc Pharmacol, 7, 513, 10.2174/157016109789043883 Ordovas, 2010, Epigenetics and cardiovascular disease, Nat Rev Cardiol, 7, 510, 10.1038/nrcardio.2010.104 Krause, 2016, [General concepts of epigenetics: Projections in paediatrics], Rev Chil Pediatr, 87, 4, 10.1016/j.rchipe.2015.12.002 Hamik, 2006, Transcriptional regulators of angiogenesis, Arterioscler Thromb Vasc Biol, 26, 1936, 10.1161/01.ATV.0000232542.42968.e3 Ribatti, 2009, Morphological and molecular aspects of physiological vascular morphogenesis, Angiogenesis, 12, 101, 10.1007/s10456-008-9125-1 Casanello, 2014, Endothelial heterogeneity in the umbilico-placental unit: DNA methylation as an innuendo of epigenetic diversity, Front Pharmacol, 5, 49, 10.3389/fphar.2014.00049 Fish, 2006, Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium, Cell Mol Life Sci, 63, 144, 10.1007/s00018-005-5421-8 Matouk, 2008, Epigenetic regulation of vascular endothelial gene expression, Circ Res, 102, 873, 10.1161/CIRCRESAHA.107.171025 El-Osta, 2008, Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia, J Exp Med, 205, 2409, 10.1084/jem.20081188 Lagarkova, 2008, Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes, Cell Cycle, 7, 2929, 10.4161/cc.7.18.6700 Fish, 2007, Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase, J Biol Chem, 282, 15652, 10.1074/jbc.M608318200 Fish, 2010, Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones, J Biol Chem, 285, 810, 10.1074/jbc.M109.067868 Rossler, 2004, Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site, J Cell Biochem, 93, 153, 10.1002/jcb.20133 Yu, 2004, Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription, J Biol Chem, 279, 46954, 10.1074/jbc.M407192200 Chan, 2005, Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells, J Immunol, 175, 3846, 10.4049/jimmunol.175.6.3846 Hanson, 2011, Developmental plasticity and developmental origins of non-communicable disease: Theoretical considerations and epigenetic mechanisms, Prog Biophys Mol Biol, 106, 272, 10.1016/j.pbiomolbio.2010.12.008 Banister, 2011, Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas, Epigenetics, 6, 920, 10.4161/epi.6.7.16079 Delahaye, 2014, Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth, Nat Commun, 5, 5187, 10.1038/ncomms6187 Martinez, 2014, In utero undernutrition in male mice programs liver lipid metabolism in the second-generation offspring involving altered Lxra DNA methylation, Cell Metab, 19, 941, 10.1016/j.cmet.2014.03.026 Heijmans, 2008, Persistent epigenetic differences associated with prenatal exposure to famine in humans, Proc Natl Acad Sci U S A, 105, 17046, 10.1073/pnas.0806560105